NCT04171583 (mucostaph) is a clinical trial in Staphylococcus Aureus Pneumonia, sponsored by University Hospital Muenster.

Who is sponsoring NCT04171583?

NCT04171583 is sponsored by University Hospital Muenster.

What condition does NCT04171583 study?

NCT04171583 studies Staphylococcus Aureus Pneumonia, Lung Diseases, Cystic Fibrosis, Lung Function Decreased.

Is NCT04171583 still recruiting?

NCT04171583 is currently completed. Last updated 2 February 2023.

Last reviewed 2023-02-02 · How we verify

NCT04171583: mucostaph

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways

Completed Last updated 2 February 2023

What this trial tests

trial in Staphylococcus Aureus Pneumonia in 628 participants. Completed in 31 July 2022.

Timeline

1 March 2019

Primary endpoint
31 July 2022

31 July 2022

Quick facts

Lead sponsor	University Hospital Muenster
Status	Completed
Study type	OBSERVATIONAL
Enrollment	628
Start date	1 March 2019
Primary completion	31 July 2022
Estimated completion	31 July 2022
Sites	13 locations across Austria, Germany

Conditions studied

Staphylococcus Aureus Pneumonia — all drugs for Staphylococcus Aureus Pneumonia →
Lung Diseases — all drugs for Lung Diseases →
Cystic Fibrosis — all drugs for Cystic Fibrosis →
Lung Function Decreased — all drugs for Lung Function Decreased →

Sponsor

University Hospital Muenster

Who can join

Eligibility, any sex, with Staphylococcus Aureus Pneumonia or Lung Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recently, the investigators described a new mucoid phenotype of Staphylococcus aureus cultured from the airways of cystic fibrosis (CF) patients.In this observational study, the investigators plan to determine the prevalence of mucoid S. aureus in respiratory specimens of CF patients and a possible impact of mucoid S. aureus on lung disease severity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mucoid <i>Staphylococcus aureus</i>: A Clinical Trial of Its Prevalence and Association with Lung Function in People with Cystic Fibrosis.
Rumpf CH, Janssen T, Hait RJ, Romme K, et al · · 2025 · cited 2× · PMID 39918841 · DOI 10.1164/rccm.202407-1474oc

Verify or expand the search:

Other University Hospital Muenster trials

Trials by the same sponsor.

NCT07414498 — MICRO-SURG: Subgingival Microbiome in Peri-Implantitis, Regenerative, and Resective Periodontal Surgery · NA · not yet recruiting
NCT06999174 — Multiparametric MRI for Characterization of Hepatocellular Carcinoma · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting
NCT06648733 — Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care · NA · recruiting
NCT06464302 — Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized R · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04171583 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Muenster
Last refreshed: 2 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04171583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing